Trial Profile
A Phase IIb Clincal Trial Treating Patients with Advanced Liver Cancer with PTS (Para-Toluenesulfonamide Injection), A Novel Local Invasive Anticancer Drug, by Percutaneous Intratumoral Injection Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs P-toluenesulfonamide (Primary)
- Indications Hepatic tumours; Liver cancer; Liver metastases
- Focus Therapeutic Use
- 22 Jan 2013 New trial record